Exagen (XGN) Amortization of Deferred Charges (2018 - 2026)
Exagen filings provide 9 years of Amortization of Deferred Charges readings, the most recent being $133000.0 for Q1 2026.
- On a quarterly basis, Amortization of Deferred Charges rose 216.67% to $133000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $469000.0, a 194.97% increase, with the full-year FY2025 number at $378000.0, up 145.45% from a year prior.
- Amortization of Deferred Charges hit $133000.0 in Q1 2026 for Exagen, up from $131000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $333000.0 in Q3 2022 to a low of -$25000.0 in Q3 2024.
- Median Amortization of Deferred Charges over the past 5 years was $79000.0 (2025), compared with a mean of $92882.4.
- Biggest five-year swings in Amortization of Deferred Charges: soared 932.5% in 2022 and later plummeted 136.76% in 2024.
- Exagen's Amortization of Deferred Charges stood at $140000.0 in 2022, then plummeted by 50.71% to $69000.0 in 2023, then crashed by 39.13% to $42000.0 in 2024, then surged by 211.9% to $131000.0 in 2025, then rose by 1.53% to $133000.0 in 2026.
- The last three reported values for Amortization of Deferred Charges were $133000.0 (Q1 2026), $131000.0 (Q4 2025), and $126000.0 (Q3 2025) per Business Quant data.